July 16, 2010
Baylor College of Medicine Investigates Professor Over Avandia Article
Justin Sullivan, Getty Images
The diabetes drug Avandia was praised in a 2001 journal article that appears to have been ghostwritten by the manufacturer.
Enlarge Image
Justin Sullivan, Getty Images
The diabetes drug Avandia was praised in a 2001 journal article that appears to have been ghostwritten by the manufacturer.
One day after a federal advisory panel expressed safety concerns about GlaxoSmithKline's diabetes drug Avandia, the Baylor College of Medicine said on Thursday that it is considering whether to penalize an assistant professor who apparently allowed his name to be used on a ghostwritten article that was favorable to the medication.
Internal company e-mail messages released this week by Senate investigators looking into the marketing of Avandia indicated that Steven M. Haffner, who
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
